PharmaCielo
Manufacturing · Canada · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1 Toronto St Ste 805, Toronto, Ontario, ...Phone Number
(647) 560-4640Website
www.pharmacielo.comRevenue
<$5 MillionStock Symbol
PCLOFIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About PharmaCielo
PharmaCielo is a leading provider of medicinal cannabis, specializing in the cultivation and extraction of high-quality flower and extracts. The company operates large-scale production facilities in Colombia, leveraging the region's ideal growing conditions to ensure a reliable supply of pharmaceutical-grade products. With a focus on quality and safety, PharmaCielo employs advanced scientific methods and state-of-the-art technology to produce both psychoactive and non-psychoactive extracts. Their product range includes CBD isolate, which is refined to its purest form for precise applications.Explore more
PharmaCielo Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PharmaCielo your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on PharmaCielo recently announced quarterly report
Click to see if PharmaCielo had a recent Job posting/layoffs
Product Launch: Get notified when PharmaCielo launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at PharmaCielo
Check out if PharmaCielo is spiking on competitors!
Funding: Get notified immidiatlly once PharmaCielo has new funding data
PharmaCielo, which may be a good buyer, showed buying intent in Masked Content Topic
Check if PharmaCielo has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined PharmaCielo as Masked Content
Find 3 more new buyers
Compare Similar Companies to PharmaCielo
Compare insights from companies similar to PharmaCielo, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$27.5M
201-500
Public
$210M
2012
AP
Andrew PollockVice President, Marketing, The Green Organic Dutchman (Tgod)
Company Profile Activity
Activity Insights
PharmaCielo is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PharmaCielo is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PharmaCielo.
PharmaCielo financials insights
Gather financial insights about PharmaCielo, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$3M
2016
Private Equity
$4M
2017
Private Equity
$2M
2022
Debt
$5M
PharmaCielo Tech Stack
A closer look at the technologies used by PharmaCielo
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Executive Move
Board of Directors
Executive Move
Marc Lustig, Lead Director of the Board, has been named Chairman & Chief Executive Officer.
Funding
PharmaCielo News & Media
PharmaCielo Ltd. announced that it expects to receive CAD 2 million in funding
announced a non-brokered private placement of 9,090,909 units at an issue price of CAD 0.22 per unit for the gross proceeds of CAD 1,999,999.98 on April 10, 2024. Each Unit will be comprised of one...PharmaCielo Announces Q3 2023 Financial Results
All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - November 29, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced financial results for the third quarter ended September 30, 2023. Summary Financials Three months...PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement
Today the Company closed the latest tranche consisting of 1,500 units for aggregate proceeds of $1,500,000.The Company also announced that it has agreed to issue shares and debt in settlement of certain amounts owing.Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - October 6, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts,...PharmaCielo Announces Q2 2023 Financial Results
All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 29, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced financial results for the second quarter ended June 30, 2023. Management Commentary Marc Lustig, Chairman.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding PharmaCielo
Sign Up For FreeTo access detailed company insights
PharmaCielo is a leading provider of medicinal cannabis, specializing in the cultivation and extraction of high-quality flower and extracts. The company operates large-scale production facilities in Colombia, leveraging the region's ideal growing conditions to ensure a reliable supply of pharmaceutical-grade products. With a focus on quality and sa... Read More
